Previous studies have shown the potential for intervertebral disc tissue regeneration is very limited. While in vivo and in vitro studies have shown that traction can restore disc height and internal pressure, in many clinical studies it was shown that axial mechanical traction for the treatment of low back pain is ineffective.
from Sports Medicine via xlomafota13 on Inoreader https://ift.tt/2SHUnHi
via IFTTT
Σάββατο 3 Νοεμβρίου 2018
Controlled immobilization-traction based on intervertebral stability is conducive to the regeneration or repair of the degenerative disc
Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma
The association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin's Lymphomas (NHL) is well established. Antiviral therapy (AVT) is the first line treatment for HCV-related indolent NHL whereas diffuse large B-cell lymphoma (DLBCL) requires immediate start of chemoimmunotherapy (CIT), usually deferring AVT. However, an early HCV elimination may reduce the risk of CIT-induced liver toxicity and consequent CIT interruption or withdrawal. To date few data are available on safety and efficacy of concomitant administration of direct-acting antivirals (DAA) and CIT in HCV-associated DLBCL.
from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2P5iHog
via IFTTT
Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine
Cyclosporine (CSA) is an alternative treatment for autoimmune hepatitis (AIH), however, its unknown long-term safety and efficacy have limited its use.
from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2CXkYL7
via IFTTT
Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma
The association between hepatitis C virus (HCV) infection and B-cell non-Hodgkin's Lymphomas (NHL) is well established. Antiviral therapy (AVT) is the first line treatment for HCV-related indolent NHL whereas diffuse large B-cell lymphoma (DLBCL) requires immediate start of chemoimmunotherapy (CIT), usually deferring AVT. However, an early HCV elimination may reduce the risk of CIT-induced liver toxicity and consequent CIT interruption or withdrawal. To date few data are available on safety and efficacy of concomitant administration of direct-acting antivirals (DAA) and CIT in HCV-associated DLBCL.
from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2P5iHog
via IFTTT
Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine
Cyclosporine (CSA) is an alternative treatment for autoimmune hepatitis (AIH), however, its unknown long-term safety and efficacy have limited its use.
from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2CXkYL7
via IFTTT
The forty years of medical genetics in China
Publication date: Available online 3 November 2018
Source: Journal of Genetics and Genomics
Author(s): Lei Cai, Lan Alice Zheng, Lin He
Abstract
Medical genetics is the newest cutting-edge discipline that focuses on solving medical problems using genetics knowledge and methods. In China, medical genetics research activities initiated from a poor inner basis but a prosperous genetics development outer environment. During the 40 years of reform and opening-up policy, Chinese scientists contributed significantly in the field of medical genetics, garnering considerable attention worldwide. In this review, we highlight the significant findings and/or results discovered by Chinese scientists in monogenic diseases, complex diseases, cancer, genetic diagnosis, as well as gene manipulation and gene therapy. Due to these achievements, China is widely recognized to be at the forefront of medical genetics research and development. However, the significant progress and development that has been achieved could not have been accomplished without sufficient funding and a well-constructed logistics network. The successful implementation of translational medicine or precise medicine sourced from medical genetics will depend on a strong foundation based on an open ethic policy and strong support at the Chinese national industry level.
from Genetics via xlomafota13 on Inoreader https://ift.tt/2D2HFNM
via IFTTT
Fruit fly research in China
Publication date: Available online 3 November 2018
Source: Journal of Genetics and Genomics
Author(s): Ying Cheng, Dahua Chen
Abstract
Served as a model organism over a century, fruit fly has significantly pushed forward the development of global scientific research, including in China. The high similarity in genomic features between fruit fly and human enables this tiny insect to benefit the biomedical studies of human diseases. In the past decades, Chinese biologists have used fruit fly to make numerous achievements on understanding the fundamental questions in many diverse areas of biology. Here, we review some of the recent fruit fly studies in China, and mainly focus on those studies in the fields of stem cell biology, cancer therapy and regeneration medicine, neurological disorders and epigenetics.
from Genetics via xlomafota13 on Inoreader https://ift.tt/2PajQv1
via IFTTT